Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Real Biotech Corporation (RBC) is a Taiwan-based biotechnology company that specializes in the production of molecular biology reagents and kits for the global life sciences market. Founded in 2005, the company provides a wide array of products for DNA/RNA extraction, PCR amplification, cloning, and protein purification, marketed under the HiYield and Real Genomics brands. RBC serves as a key supplier for academic research, clinical diagnostics, and industrial biotechnology, offering both catalog products and OEM/ODM manufacturing services. The company's focus is on providing high-purity, reliable tools to facilitate genomic and proteomic workflows. With a strong international distribution network, RBC supports researchers in over 60 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Real Biotech.